TABLE 3.
Variable | Study (ADHD) group (n = 4,132) | Control (non-ADHD) group (n = 4,132) | SMD |
Sex | <0.01 | ||
Female | 833 | 832 | |
Male | 3,299 | 3,300 | |
Age, years | 10.45 (3.24) | 10.45 (3.24) | <0.01 |
0–5 | 144 | 144 | |
6–10 | 2,107 | 2,108 | |
11–17 | 1,881 | 1,880 | |
Economic status | 12.96 (5.89) | 12.84 (5.88) | <0.01 |
<20% | 517 | 517 | |
20–80% | 2,108 | 2,107 | |
>80% | 1,507 | 1,508 | |
Region | <0.01 | ||
Rural | 911 | 912 | |
Metro | 3,221 | 3,220 | |
Atopic dermatitis | <0.01 | ||
Yes | 366 | 365 | |
No | 3,766 | 3,767 | |
Allergic rhinitis | <0.01 | ||
Yes | 242 | 240 | |
No | 3,890 | 3,892 | |
CCI | 0.10 (0.32) | 0.10 (0.32) | <0.01 |
0 | 3,737 | 3,738 | |
1 | 374 | 374 | |
2 | 21 | 20 |
SMD, standardized mean difference and CCI, Charlson comorbidity index.